Cooley has advised Avenzo Therapeutics. Ropes & Gray has advised Rallybio Corporation. Mintz has advised the placement agents. Rallybio Corporation has entered into a definitive agreement...
Rallybio to Acquire Avenzo Therapeutics and Complete $215 Million Private Placement
Rallybio to Acquire Candid Therapeutics in Merger and $505 Million Financing
Ropes & Gray has advised Rallybio. Wilson Sonsini Goodrich & Rosati has advised Candid Therapeutics on patent matters. Rallybio Corporation and Candid Therapeutics have entered into...
Rallybio’s $50 Million Common Stock Offering
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
Rallybio’s Acquisition of Worldwide License Rights to KY 1066
Wiggin and Dana represented Rallybio Corporation on the acquisition. Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming...